Sigachi Industries Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹113 Cr +35.2% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
S

Sigachi Industries Ltd

Q4 FY26Pharmaceuticals & Biotechnology

Sigachi Industries Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹92Cr
−18.9% YoY
+0.1% QoQ
Net profit
₹5Cr
−29.7% YoY
+67.6% QoQ
Margin
13.25%
−3.2 pp YoY
+5.5 pp QoQ

What the Q4 FY26 call signalled

4 of 4 strong

RevenueGood growth
MarginMargins up
CapexCapex planned
FundraiseFundraise planned
Price₹30
Market cap₹995 Cr
P/E30.6

The short version

Sigachi expects revenue for FY27 in the range of INR 650-675 crores, supported by incremental capacities from Dahej and Jhagadia and an improved product mix. FY27 revenue guidance: INR 650-675 crores with EBITDA margin of 18-20%, improved from current margins (~7%) - Utilization and margins expected to normalize by FY27 to mid-FY28, with margins reaching

From Sigachi Industries Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Good growth
  • Sigachi expects revenue for FY27 in the range of INR 650-675 crores, supported by incremental capacities from Dahej and Jhagadia and an improved product mix.
  • Expansion includes 12,000 metric tons capacity increase at Dahej H2 with CapEx of INR 106 crores, plus new CCS capacity (~INR 90 crores CapEx) expected to commercialize by Q1 FY28.
  • Full capacity including MCC and CCS is expected to boost revenues significantly beyond FY27; the company targets INR 1000 crores turnover by around FY29.
  • Volume growth expected from capacity expansion (from current 18,000 metric tons plus an additional 12,000 metric tons).
  • API segment revenue is projected to increase from 14% to about 18-20% of total revenue, adding to topline growth.

2 more points from Sigachi Industries Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Sigachi Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Ongoing CapEx for expanding MCC capacity by 12,000 metric tons at Dahej H2 with a cost of around INR 106 crores.
  • CapEx for CCS project totaling around INR 90 crores, expected to commercialize by Q1 FY28.
  • Dahej has 20 acres of land and Kurnool has 25 acres available for future capacity expansions.

2 more points from Sigachi Industries Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Pharmaceuticals & Biotechnology

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
2KRM Ayurveda
Rev 1Mar 1
3
Rev 1Mar 2
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Sigachi Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The company mentioned ongoing business talks and some clients already lined up supporting revenue growth.
  • Expected revenue from the new 12,000 metric tons capacity expansion is around INR 200-220 crores.
  • From the Contract Custom Synthesis (CCS) segment, approximately INR 100 crores of revenue is anticipated.
  • Demand for CCS is good, with inquiries and customers requesting dispatches alongside MCC, indicating a healthy order pipeline.
  • Current focus is on gradually increasing MCC utilization from 75-80% to 90-95% during the year.

2 more points from Sigachi Industries Ltd's call on order book

Create a free account to keep reading this call

Sigachi Industries Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Sigachi Industries Ltd Q4 FY26 results — key figures

Sigachi Industries Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue92114-18.9%92+0.1%
Operating profit (EBITDA)1219-34.8%7+70.2%
Operating margin13.25%16.47%-3.2 pp7.79%+5.5 pp
Profit before tax614-58.7%1+461.4%
Net profit (PAT)57-29.7%3+67.6%
EPS (₹)0.130.18-27.8%0.08+62.5%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹113 Cr, net profit ₹9 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Pharmaceuticals & Biotechnology this season

  • Balaxi Pharma (Q4 FY26)

    Q4 FY26 consolidated revenue: ₹70.71 crore, down 7.3% YoY from ₹76.27 crore in Q4 FY25 (Page 22). Key investor presentation takeaways from Balaxi Pharma's Q4 FY

  • Accretion Pharmaceuticals (Q4 FY26)

    45.89 crore, up 18.24% YoY (Page 28). Key investor presentation takeaways from Accretion Pharmaceuticals Ltd's Q4 FY26 investor presentation — and how it ranks

  • Gujarat Themis Biosyn (Q4 FY26)

    . Key investor presentation takeaways from Gujarat Themis Biosyn Ltd's Q4 FY26 investor presentation — and how it ranks against sector peers.

  • Aptus Pharma (Q4 FY26)

    The investor presentation reports quarterly revenue of ₹40.36 crore for Q4 FY2026. Key concall takeaways from Aptus Pharma Ltd's Q4 FY26 earnings call — and…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Sigachi Industries Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Sigachi Industries Ltd Q4 FY26 results?

Sigachi expects revenue for FY27 in the range of INR 650-675 crores, supported by incremental capacities from Dahej and Jhagadia and an improved product mix. FY27 revenue guidance: INR 650-675 crores with EBITDA margin of 18-20%, improved from current margins (~7%) - Utilization and margins expected to normalize by FY27 to mid-FY28, with margins reaching

What is Sigachi Industries Ltd share price analysis?

Sigachi Industries Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 30.6 with a market cap of ₹995 Cr. Investors should review the full earnings analysis for detailed insights.

Is Sigachi Industries Ltd planning capital expenditure?

Ongoing CapEx for expanding MCC capacity by 12,000 metric tons at Dahej H2 with a cost of around INR 106 crores.

Keep Sigachi Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.